Confirmed speakers:


Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ]

Dr. Jeffrey M. Friedman Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA

Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan

Dr. Philip Barter Professor and Director, Heart Research Institute, University of Sydney, Australia

Dr. Jean-Charles Fruchart Head, Department of Atherosclerosis, Institut Pasteur de Lille, FranceFounder and President, Genfit, France

Dr. Goran HanssonProfessor & Head, Cardiovascular Research Laboratory, Center for Molecular Medicine,Karolinska Institute, Sweden

Dr. John Chapman Director, Dyslipidemia and Atherosclerosis Research Unit, INSERM, France

Dr. Alan S. Maisel Professor of Medicine Director, Coronary Care Unit and Heart Failure Program, Veterans Affairs San Diego Healthcare System, Univ of California, San Diego, USA

Dr. Matthias H. Tschöp Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA

Dr. Walter Wahli Founder Director, Centre for Integrative Genomics, Switzerland

Dr. Per-Olof Berggren The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institute, Sweden

Dr. Charles Burant Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA

Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University / Retired Group Vice President, Eli Lilly & Company, USA

Dr. Stanley T. Crooke Chairman & CEO, Isis Pharmaceuticals, Inc

Dr. Michael R. Jirousek Senior Vice President, Research, Sirtris Pharmaceuticals, Inc.

Dr. Uwe Schoenbeck Vice President, Therapeutic Area Head, Cardiovascular Disease, Boehringer Ingelhiem

Dr. Gianni Gromo Global Head Metabolic & Vascular Disease Area, Hoffmann-La Roche AG

Dr. Steve Harrison Vice President, Research, KAI Pharmaceuticals